DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
103 hedge funds and large institutions have $622M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 50 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
+8
Holders Change %
+8.42%
% of All Funds
2.3%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
22
Increased
50
Reduced
19
Closed
13
Calls
$133K
Puts
$1K
Net Calls
+$132K
Net Calls Change
+$122K
Top Buyers
| 1 |
BlackRock
New York
|
$46.3M |
| 2 |
State Street
Boston,
Massachusetts
|
$21.9M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
$32.6M |
| 4 |
RI
RTW Investments
New York
|
$63.1M |
| 5 |
SCM
Sio Capital Management
New York
|
$4.74M |
